Deborah Miller

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. pmc Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis
    Deborah M Miller
    Mellen Center, Cleveland Clinic, USA
    Mult Scler 22:830-41. 2016
  2. doi Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA
    Mult Scler 21:457-65. 2015
  3. doi Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a
    D M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, U 10 9500 Euclid Avenue, Cleveland, OH 44118, USA
    Mult Scler 17:734-42. 2011
  4. pmc Web-based self-management for patients with multiple sclerosis: a practical, randomized trial
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Telemed J E Health 17:5-13. 2011
  5. doi Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, U 10, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Neurol Neurosci Rep 10:397-406. 2010
  6. doi Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life
    Deborah Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, U 10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurology 74:S24-35. 2010
  7. pmc Using an automated recruitment process to generate an unbiased study sample of multiple sclerosis patients
    Deborah M Miller
    Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Telemed J E Health 16:63-8. 2010
  8. ncbi Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study
    D M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA
    Mult Scler 12:180-6. 2006
  9. ncbi Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 9:1-5. 2003
  10. ncbi Health-related quality of life in multiple sclerosis: effects of natalizumab
    Richard A Rudick
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Ann Neurol 62:335-46. 2007

Detail Information

Publications19

  1. pmc Validating Neuro-QoL short forms and targeted scales with people who have multiple sclerosis
    Deborah M Miller
    Mellen Center, Cleveland Clinic, USA
    Mult Scler 22:830-41. 2016
    ....
  2. doi Factors associated with clinically significant increased walking time in multiple sclerosis: results of a survival analysis of short-term follow-up data from a clinical database
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, USA
    Mult Scler 21:457-65. 2015
    ..Because multiple sclerosis (MS) is variable and unpredictable, if symptom worsening could be predicted, patients may feel better prepared to manage changes in function...
  3. doi Change in quality of life in patients with relapsing-remitting multiple sclerosis over 2 years in relation to other clinical parameters: results from a trial of intramuscular interferon {beta}-1a
    D M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, U 10 9500 Euclid Avenue, Cleveland, OH 44118, USA
    Mult Scler 17:734-42. 2011
    ....
  4. pmc Web-based self-management for patients with multiple sclerosis: a practical, randomized trial
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Telemed J E Health 17:5-13. 2011
    ....
  5. doi Quality of life in multiple sclerosis: determinants, measurement, and use in clinical practice
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, U 10, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Curr Neurol Neurosci Rep 10:397-406. 2010
    ....
  6. doi Patient-centered outcomes: translating clinical efficacy into benefits on health-related quality of life
    Deborah Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, U 10, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Neurology 74:S24-35. 2010
    ..However, MS-specific and hybrid instruments that possess greater sensitivity now have been developed...
  7. pmc Using an automated recruitment process to generate an unbiased study sample of multiple sclerosis patients
    Deborah M Miller
    Mellen Center for Treatment and Research in Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Telemed J E Health 16:63-8. 2010
    ..The subjects were highly representative of the target population, indicating that there was little bias in our selection process despite a constantly changing pool of eligible individuals...
  8. ncbi Change in clinician-assessed measures of multiple sclerosis and subject-reported quality of life: results from the IMPACT study
    D M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, OH 44195, USA
    Mult Scler 12:180-6. 2006
    ..The IMPACT data permit a detailed assessment of the relation between clinical and self-reported measures...
  9. ncbi Factors that predict health-related quality of life in patients with relapsing-remitting multiple sclerosis
    Deborah M Miller
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Mult Scler 9:1-5. 2003
    ....
  10. ncbi Health-related quality of life in multiple sclerosis: effects of natalizumab
    Richard A Rudick
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH 44195, USA
    Ann Neurol 62:335-46. 2007
    ..To report the relationship between disease activity and health-related quality of life (HRQoL) in relapsing multiple sclerosis, and the impact of natalizumab...
  11. ncbi Estimating long-term effects of disease-modifying drug therapy in multiple sclerosis patients
    R A Rudick
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, The Cleveland Clinic Foundation, OH 44195, USA
    Mult Scler 11:626-34. 2005
    ..The paucity of data on the long-term treatment of patients with MS may be aided by applying these or similar methods to vigorously followed cohorts of patients...
  12. pmc The Multiple Sclerosis Performance Test (MSPT): an iPad-based disability assessment tool
    Richard A Rudick
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation
    J Vis Exp . 2014
    ..This method could have the same transformative effect on clinical care and research in MS as standardized computer-adapted testing has had in the education field, with clear potential to accelerate progress in clinical care and research...
  13. doi Risk tolerance to MS therapies: Survey results from the NARCOMS registry
    Robert J Fox
    Mellen Center for Multiple Sclerosis, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA Electronic address
    Mult Scler Relat Disord 4:241-9. 2015
    ..There is little information about risk acceptance of multiple sclerosis (MS) patients to various MS therapies...
  14. ncbi Self-management in neurological disorders: systematic review of the literature and potential interventions in multiple sclerosis care
    Alex D Rae-Grant
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic, Cleveland, OH, USA
    J Rehabil Res Dev 48:1087-100. 2011
    ..We provide recommendations for future intervention study methodologies with a specific emphasis on MS care...
  15. ncbi Recovery following acute exacerbations of multiple sclerosis: from impairment to quality of life
    F Bethoux
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    Mult Scler 7:137-42. 2001
    ..Even after maximum improvement is reached, patients are left with multiple symptoms and functional limitations, and may benefit from additional rehabilitative interventions...
  16. ncbi Association of fatigue and brain atrophy in multiple sclerosis
    Ruth Ann Marrie
    Department of Neurology Mellen Center, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
    J Neurol Sci 228:161-6. 2005
    ..This suggests that the subjective complaint of fatigue is linked to destructive pathologic processes in RRMS patients...
  17. ncbi Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mult Scler 11:69-75. 2005
    ..25; 1.07-1.47). Subjectively reported impairment reflects subtle declines in PSI and IM independent of mood, fatigue, and physical impairment Cognitive complaints should not be discounted due to depression...
  18. ncbi Validity and reliability of the MSQLI in cognitively impaired patients with multiple sclerosis
    Ruth Ann Marrie
    Mellen Center for Multiple Sclerosis Treatment and Research, Department of Neurology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Mult Scler 9:621-6. 2003
    ..7). Cognitive impairment, a common MS manifestation, does not appear to reduce the reliability or validity of the MSQLI as a patient self-report measure of health status and quality of life...
  19. ncbi Health-related quality of life assessment in multiple sclerosis
    Deborah M Miller
    Department of Neurology, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic Foundation, Cleveland, OH, USA
    Rev Neurol Dis 5:56-64. 2008
    ..This article discusses the types of HRQL measures available for patient assessment and how those data can be routinely collected...

Research Grants1

  1. Using the Internet to Improve Patient's Self-Management of Chronic Illness
    Deborah Miller; Fiscal Year: 2006
    ..The utilization analysis will allow us to identify the incremental benefit of the comprehensive system compared to the secure system and to determine where there greatest savings in overall cost of care is gained. ..